[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344090-105":59,"doc-detail-344090-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cyb561-a-potential-prognostic-biomarker-for-liver-hepatocellular-carcinoma","CYB561 a potential prognostic biomarker for liver hepatocellular carcinoma","","Liver hepatocellular carcinoma shows frequent recurrence, metastasis, and poor outcomes, yet the role of cytochrome b561 (CYB561) in this disease has remained unclear. The study evaluates CYB561 expression, clinical associations, prognosis, and biological function in LIHC using TCGA, GEO, TIMER2, Kaplan–Meier Plotter, GEPIA2, and immunohistochemistry. CYB561 knockdown experiments assess proliferation and migration, while single-cell analyses map expression distribution. Results indicate CYB561 mRNA and protein are highly expressed, predict worse survival as an independent risk factor, and relate to adhesion, immune response, and tumor signaling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cyb561-a-potential-prognostic-biomarker-for-liver-hepatocellular-carcinoma/344090/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cyb561-a-potential-prognostic-biomarker-for-liver-hepatocellular-carcinoma/344090.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of studying CYB561 in liver hepatocellular carcinoma?","Question",{"text":112,"@type":113},"To determine CYB561’s prognostic value and potential biological function in LIHC, including its relation to disease behavior and the immune microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CYB561 expression assessed in LIHC samples?",{"text":117,"@type":113},"Expression was analyzed using bioinformatics databases (TCGA, GEO, TIMER2, Kaplan–Meier Plotter, GEPIA2) and confirmed in tissue by immunohistochemical staining.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the effect of CYB561 knockdown on LIHC cells?",{"text":121,"@type":113},"CYB561 knockdown inhibited LIHC cell proliferation and migration, supported by wound-healing, transwell, and clonal formation experiments.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344090,1790194077,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Clinical and Experimental Medicine (2025) 25:23 [https://doi.org/10.1007/s10238-024-01522-w](https://doi.org/10.1007/s10238-024-01522-w)  \nCYB561 a potential prognostic biomarker for liver hepatocellular carcinoma  \nYanchun Zhao1 · Jingfang Du1 · Jian Zhuo2 · Quanai Zhang2 · Luxian Dai3 · Yubao Tang3 · Yao Wang3 · Ankang Sheng3 · Hanyu Yao3 · Weiguang Liu3  \nReceived: 12 August 2024 / Accepted: 5 November 2024 / Published online: 21 December 2024 © The Author(s) 2024  \nAbstract  \nLiver hepatocellular carcinoma (LIHC) is a malignancy characterized by a high rate of recurrence, metastasis, and poor prognosis. Cytochrome b561 (CYB561) has been previously reported to be associated with tumor progression, but it has not been revealed in LIHC. The aim of this study was to investigate the prognostic value and potential function of CYB561 in LICH. The expression level, clinical correlation, prognosis, and biological function of CYB561 in LIHC were analyzed using The Cancer Genome Atlas（TCGA), Gene Expression Omnibus (GEO), TIMER2, Kaplan–Meier Plotter, and GEPIA2 databases. The expression of CYB561 in LIHC tissue samples was analyzed by immunohistochemical staining. The effect of CYB561 on the proliferation and migration of LIHC cells was investigated by using CYB561 knockdown in vitro. GSE149614 dataset was used to analyze the expression distribution of CYB561 in LIHC on a single-cell dimension. This study showed that CYB561 mRNA and protein were highly expressed in LIHC. High expression of CYB561 suggests poor prognosis in LICH patients and is an independent risk factor for LIHC. Wound-healing experiment, transwell experiment, and clonal formation experiment confirmed that CYB561 knockdown could inhibit the proliferation and migration of LIHC cells. Functional enrichment analysis showed that CYB561 was related to biological processes such as cell adhesion and immune response. KEGG enrichment analysis showed that CYB561 interacts with tumor-related signaling pathways. Singlecell analysis showed that CYB561 was mainly expressed in hepatocytes. Cells with high CYB561 expression had a higher degree of malignancy. Our study found that abnormal expression of CYB561 in LIHC suggested poor prognosis of LIHCand was related to tumor migration and proliferation. CYB561 is a potential prognostic predictor or therapeutic biomarker.  \nKeywords Cytochrome b561 (CYB561) · Liver hepatocellular carcinoma (LIHC) · Prognosis · Bioinformatics · Immune infiltration · Single-cell sequence  \nIntroduction  \nLiver hepatocellular carcinoma (LIHC) is increasingly prevalent worldwide, with a rising incidence in various regions such as East Asia, Western Europe, and the USA. Notably, LIHC ranks as the third leading cause of  \n* Weiguang Liu [lwg1943@163.com](lwg1943@163.com)  \n1 Department of Outpatient, Affiliated Hospital of Hebei University of Engineering, Handan 056000, Hebei, China  \n2 School of Clinical Medicine, The Hebei University of Engineering, Handan 056000, Hebei, China  \n3 Department of Breast Surgery, Yangzhou Maternal and Child Health Care Hospital Affliated to Yangzhou University, Yangzhou 225007, Jiangsu, China  \ncancer-related fatalities and the sixth most frequently diagnosed malignancy among all types of cancer [1] . LIHC is associated with multiple risk factors, such as viral infections like hepatitis B virus (HBV) or hepatitis C virus (HCV), alcohol abuse, non-alcoholic fatty liver disease (NAFLD), autoimmune liver diseases, drug-induced liver injury, and exposure to aflatoxins [2] . The high proliferative and invasive biological characteristics of LIHC contribute to its insidious onset, rapid progression, and poor prognosis [3] . For LIHC, classical treatment modalities include surgical resection, radiofrequency ablation, and transarterial chemoembolization, showing efficacy and significant advancements in managing localized forms of the disease. However, due to chemotherapy resistance, high rates of recurrence, and metastasis, the 5-year","cbCaiuqZVCJCDANm","https://ap.wps.com/l/cbCaiuqZVCJCDANm","pdf",11308910,13,"English","# Abstract\n## Immunohistochemistry and result interpretation","[{\"question\":\"What is the main purpose of studying CYB561 in liver hepatocellular carcinoma?\",\"answer\":\"To determine CYB561’s prognostic value and potential biological function in LIHC, including its relation to disease behavior and the immune microenvironment.\"},{\"question\":\"How was CYB561 expression assessed in LIHC samples?\",\"answer\":\"Expression was analyzed using bioinformatics databases (TCGA, GEO, TIMER2, Kaplan–Meier Plotter, GEPIA2) and confirmed in tissue by immunohistochemical staining.\"},{\"question\":\"What was the effect of CYB561 knockdown on LIHC cells?\",\"answer\":\"CYB561 knockdown inhibited LIHC cell proliferation and migration, supported by wound-healing, transwell, and clonal formation experiments.\"}]","CYB561 a potential prognostic biomarker for liver hepatocellular carcinoma | PDF",1790052992,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82cebe3cdc63910231afa1ec29a48752.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86c8e218eeed50bc9d3d2f30c303fd2e.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e43fafef3ab2807a553b43426cfc6c2.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be73950017eb839c9cb7c667c0722040.webp",980,1301]